.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Argus Health
Merck
Cipla
Fish and Richardson
US Army
McKesson
Baxter
Cantor Fitzgerald
Accenture

Generated: December 14, 2017

DrugPatentWatch Database Preview

PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Phenylephrine Hydrochloride And Promethazine Hydrochloride patents expire, and when can generic versions of Phenylephrine Hydrochloride And Promethazine Hydrochloride launch?

Phenylephrine Hydrochloride And Promethazine Hydrochloride is a drug marketed by Hi-tech Pharmacal and Vintage and is included in two NDAs.

The generic ingredient in PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE is phenylephrine hydrochloride; promethazine hydrochloride. There are twenty drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the phenylephrine hydrochloride; promethazine hydrochloride profile page.

Summary for PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE

Drug patent expirations by year for PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE

Pharmacology for PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Hi-tech PharmacalPHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDEphenylephrine hydrochloride; promethazine hydrochlorideSYRUP;ORAL040675-001Dec 23, 2014AARXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
VintagePHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDEphenylephrine hydrochloride; promethazine hydrochlorideSYRUP;ORAL040654-001Dec 7, 2006AARXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Deloitte
QuintilesIMS
Baxter
McKesson
Cipla
Johnson and Johnson
Moodys
Daiichi Sankyo
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot